The use of recombinant factor VIIa for severe intractable bleeding during spine surgery.
Kaw LL, Jr., Coimbra R, Potenza BM, Garfin SR, Hoyt DB
Spine 2004;29(12):1384-1387.
Review by
Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A.
Tranholm M, Kristensen K, Kristensen AT, Pyke C, Rojkjaer R, Persson E
Blood 2003;102(10):3615-3620.
Review by
Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism.
Wilbourn B, Harrison P, Mackie IJ, Liesner R, Machin SJ
Br J Haematol 2003;122(4):651-661.
Review by Aldouri M
Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders.
Galan AM, Tonda R, Pino M, Reverter JC, Ordinas A, Escolar G
Transfusion 2003;43(7):885-892.
Review by
Possible role of recombinant activated factor VII (RFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E
Can J Anaesth 2002;49(10):S15-S20.
Review by
Sequential treatment with bolus and continuous infusion of recombinant factor VIIa for hip arthroplasty in a patient with haemophilia A and inhibitor.
Perez R, Martinez ML, Pinero A, Sosa R
Haemophilia 2002;8(6):822-825.
Review by Aldouri M
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial.
Friederich PW, Henny CP, Messelink EJ, et al.
Lancet 2003;361(9353):201-205.
Review by
Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device.
Potapov EV, Pasic M, Bauer M, Hetzer R
Ann Thorac Surg 2002;74(6):2182-2183.
Review by Aldouri M
NovoSeven: mode of action and use in acquired haemophilia.
Von Depka M
Intensive Care Med 2002;28(Suppl 2):S222-S227.
Review by M. Aldouri
Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
Kessler C
Intensive Care Med 2002;28(Suppl 2):S228-S234.
Review by Aldouri M
Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy.
Mayer SA
Intensive Care Med 2002;28(Suppl 2):S235-S240.
Review by Aldouri M
Updates in the management of severe coagulopathy in trauma patients.
Lynn M, Jeroukhimov I, Klein Y, Martinowitz U
Intensive Care Med 2002;28(Suppl 2):S241-S247.
Review by Aldouri M
Orthopaedic surgery in haemophilic patients with inhibitors: an overview.
Hvid I, Rodriguez-Merchan EC
Haemophilia 2002;8(3):288-291.
Review by
Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage.
Gerotziafas GT, Zervas C, Gavrielidis G, et al.
Am J Hematol 2002;69(3):219-222.
Review by M. Aldouri
Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor.
Carr ME, Loughran TP, Cardea JA, Smith WK, Kuhn JG, Dottore MV
Int J Hematol 2002;75(1):95-99.
Review by
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659